Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point. R&D for neglected diseases has increased with new funding and collaborations taking place mainly through product development partnerships (PDPs). PDPs are self-governing, private non-profit R&D organizations. In contrast to push and pull instruments designed to address private-sector R&D underinvestment, PDPs have emerged voluntarily to address this public health challenge. In this study we examine how non-profit R&D collaboration for neglected diseases takes place through PDPs. We find that PDPs act as 'system integrators' that leverage the resources and capabilities of a network of public, philanthropic and private-sector partners.
- o31 - Innovation and Invention: Processes and Incentives
- o30 - "Technological Change; Research and Development; Intellectual Property Rights: General"
- R&D collaboration
- neglected diseases
- DRUG DEVELOPMENT
- PHARMACEUTICAL INNOVATION
Munoz, V., Visentin, F., Foray, D., & Gaule, P. (2015). Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases. Science and Public Policy, 42(3), 315-338. https://doi.org/10.1093/scipol/scu049